Challenges and enablers of deprescribing: a general practitioner perspective NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff PloS one 11 (4), e0151066, 2016 | 210 | 2016 |
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities N Ailabouni, D Mangin, PS Nishtala International journal of clinical pharmacy 41 (1), 167-178, 2019 | 108 | 2019 |
General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study NJ Ailabouni, PS Nishtala, D Mangin, JM Tordoff International Journal of Clinical Practice 70 (3), 261-276, 2016 | 71 | 2016 |
Consumer attitudes towards deprescribing: a systematic review and meta-analysis KR Weir, NJ Ailabouni, CR Schneider, SN Hilmer, E Reeve The Journals of Gerontology: Series A 77 (5), 1020-1034, 2022 | 69 | 2022 |
Alterations in drug disposition in older adults: a focus on geriatric syndromes D Maher, N Ailabouni, AA Mangoni, MD Wiese, E Reeve Expert opinion on drug metabolism & toxicology 17 (1), 41-52, 2021 | 50 | 2021 |
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities N Ailabouni, D Mangin, PS Nishtala BMJ open 7 (4), e013800, 2017 | 35 | 2017 |
COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy NJ Ailabouni, SN Hilmer, L Kalisch, R Braund, E Reeve The Journals of Gerontology: Series A 76 (6), 1068-1073, 2021 | 34 | 2021 |
Barriers and enablers of older adults initiating a deprescribing conversation NJ Ailabouni, KR Weir, E Reeve, JT Turner, JW Norton, SL Gray Patient Education and Counseling 105 (3), 615-624, 2022 | 26 | 2022 |
Leveraging implementation science to increase the translation of deprescribing evidence into practice NJ Ailabouni, E Reeve, CD Helfrich, SN Hilmer, BH Wagenaar Research in Social and Administrative Pharmacy 18 (3), 2550-2555, 2022 | 24 | 2022 |
Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial H Jamieson, PS Nishtala, HU Bergler, SK Weaver, JW Pickering, ... The Journals of Gerontology: Series A 78 (9), 1692-1700, 2023 | 19 | 2023 |
Do residents need all their medications? A cross-sectional survey of RNs' views on deprescribing and the role of clinical pharmacists N Ailabouni, J Tordoff, D Mangin, PS Nishtala Journal of Gerontological Nursing 43 (10), 13-20, 2017 | 17 | 2017 |
Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria NJ Ailabouni, PS Nishtala, JM Tordoff European Geriatric Medicine 7 (1), 40-46, 2016 | 16 | 2016 |
Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand JM Tordoff, NJ Ailabouni, DP Browne, HS Al-Sallami, AR Gray International journal of clinical pharmacy 38, 941-949, 2016 | 11 | 2016 |
Medication use quality and safety in older adults: 2018 update NJ Ailabouni, ZA Marcum, KE Schmader, SL Gray Journal of the American Geriatrics Society 67 (12), 2458-2462, 2019 | 8 | 2019 |
Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer’s Disease and Related Dementias D Barthold, ZA Marcum, S Chen, L White, N Ailabouni, A Basu, NB Coe, ... Journal of General Internal Medicine 36, 863-868, 2021 | 7 | 2021 |
Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis NJ Ailabouni, E Reeve Research in social & administrative pharmacy: RSAP 15 (11), 1379-1380, 2019 | 7 | 2019 |
Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the patients’ attitudes towards deprescribing questionnaire KR Weir, NJ Ailabouni, CR Schneider, SN Hilmer, E Reeve Research in Social and Administrative Pharmacy 18 (2), 2345-2349, 2022 | 6 | 2022 |
Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older … U Bergler, NJ Ailabouni, JW Pickering, SN Hilmer, D Mangin, PS Nishtala, ... Trials 22, 1-12, 2021 | 5 | 2021 |
Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: Gathering unanswered research questions E Reeve, L Chenoweth, M Sawan, TA Nguyen, L Kalisch Ellett, ... Journal of Alzheimer's Disease 91 (3), 933-960, 2023 | 4 | 2023 |
Medication Use Quality and Safety in older adults: 2019 update NJ Ailabouni, ZA Marcum, KE Schmader, SL Gray Journal of the American Geriatrics Society 69 (2), 336-341, 2021 | 3 | 2021 |